Insulin Delivery Devices Market to Surpass US$ 17.83 Billion by 2025

1
(No Transcript)
2

• REPORT DESCRIPTION

Insulin Delivery Devices Market
Overview Insulin is vital for people suffering
from type 1 diabetes and type 2 diabetes. In the
past, patients with diabetes had to inject
insulin using large glass syringes and reusable
needles, both of which needed sterilization by
boiling after each use. Improvements and
innovations has led to development of insulin
delivery devices such as pens and insulin pumps.
Furthermore, insulin analogs have become
available that enable both continuous
subcutaneous insulin infusion(CSII) using an
insulin pump and insulin therapy using multiple
daily injections (MDI) to more closely match
physiologic insulin patterns. Type or dosage of
insulin can be changed, to meet the individual
needs of the patient. Insulin can be packaged in
vials (bottles), cartridges or prefilled pens.
The cartridges are used with pen injectors
whereas the vials are used with syringes. The
global insulin delivery devices market was valued
at US 11,326.9 million in 2017 and is expected
to witness a CAGR of 11.3 over the forecast
period (20172025). Increasing prevalence and
incidence of diabetes is a major factor driving
the insulin delivery devices market growth.
According to the Centers for Disease Control and
Prevention (CDC), 2014, about 29.1 million people
in the U.S. have diabetes with a healthcare
burden of around US 245 Bn and with an estimated
4.69.2 of pregnant women affected by
gestational diabetes. Moreover, the Australian
government launched National Diabetes Strategy
(201620), for an action to prevent diabetes and
support the people living with diabetes. Thus,
rise in government initiatives to support
diabetic patients is expected to favor growth of
the insulin delivery devices market.
3
REPORT DESCRIPTION

• Insulin Delivery Devices Market Taxonomy
• By Product Type
• Insulin Syringes
• Insulin Pens
• Insulin Pumps
• Insulin Jet Injectors
• By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• By Geography
• North America
• Asia Pacific
• Europe
• Latin America
• Request report sample for more professional and
  technical insights https//www.coherentmarketinsi
  ghts.com/insight/request-sample/1352

4
REPORT DESCRIPTION
Insulin Delivery Devices Market Key
Players Major players involved in the global
insulin delivery devices market include Key
players in the market are focusing on developing
next generation devices to remain competitive,
while seeking ways to enhance their design
capabilities. For instance, in October 2017, Eli
Lilly and Company announced its plans to invest
US 72 million in an insulin manufacturing
project at one of its Indianapolis facilities.
The investment will be used to replace an
existing insulin vial filling line and allow
Lilly to meet growing demand for its insulins -
including Humalog (insulin lispro) and Humulin
(human insulin) - while upgrading to
state-of-the-art technology and preparing for its
insulin pipeline. Click here to know more about
this publish report https//www.coherentmarketins
ights.com/market-insight/insulin-delivery-devices-
market-1352
5
(No Transcript)
6
(No Transcript)
7
(No Transcript)
8
THANK YOU
To know more about us, visit our website
www.coherentmarketinsights.com For sales
queries or new topics email us on
sales_at_coherentmarketinsights.com For other
queries contact Mr. Shah (Manager - Business Deve
lopment) Coherent Market Insights sales_at_coherentm
arketinsights.com 1-206-701-6702